JP2004502691A - 抗癌薬としての置換トリアゾロピリミジン - Google Patents

抗癌薬としての置換トリアゾロピリミジン Download PDF

Info

Publication number
JP2004502691A
JP2004502691A JP2002507815A JP2002507815A JP2004502691A JP 2004502691 A JP2004502691 A JP 2004502691A JP 2002507815 A JP2002507815 A JP 2002507815A JP 2002507815 A JP2002507815 A JP 2002507815A JP 2004502691 A JP2004502691 A JP 2004502691A
Authority
JP
Japan
Prior art keywords
chloro
triazolo
pyrimidine
carbon atoms
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002507815A
Other languages
English (en)
Japanese (ja)
Inventor
マーク・アール・シュミット
ドナルド・アール・カーシュ
ジェーン・イー・ハリス
カール・エフ・バイヤー
クラウス−ユルゲン・ペース
パウル・カルター
バルデマー・プフレングレ
グイド・アルベルト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of JP2004502691A publication Critical patent/JP2004502691A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2002507815A 2000-06-30 2001-06-28 抗癌薬としての置換トリアゾロピリミジン Pending JP2004502691A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21558500P 2000-06-30 2000-06-30
PCT/US2001/020672 WO2002002563A2 (en) 2000-06-30 2001-06-28 Substituted-triazolopyrimidines as anticancer agents

Publications (1)

Publication Number Publication Date
JP2004502691A true JP2004502691A (ja) 2004-01-29

Family

ID=22803554

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002507815A Pending JP2004502691A (ja) 2000-06-30 2001-06-28 抗癌薬としての置換トリアゾロピリミジン

Country Status (24)

Country Link
US (1) US7329663B2 (enExample)
EP (1) EP1307200A2 (enExample)
JP (1) JP2004502691A (enExample)
KR (1) KR20030013475A (enExample)
CN (1) CN1592624A (enExample)
AR (1) AR034553A1 (enExample)
AU (2) AU7306201A (enExample)
BG (1) BG107277A (enExample)
BR (1) BR0112038A (enExample)
CA (1) CA2413802A1 (enExample)
CZ (1) CZ20024150A3 (enExample)
EA (1) EA006483B1 (enExample)
GE (1) GEP20053688B (enExample)
HK (1) HK1052646A1 (enExample)
HU (1) HUP0300798A3 (enExample)
IL (1) IL152869A0 (enExample)
IN (1) IN2003KO00001A (enExample)
MX (1) MXPA02011913A (enExample)
NO (1) NO20026195L (enExample)
NZ (1) NZ523807A (enExample)
PL (1) PL360027A1 (enExample)
SK (1) SK18412002A3 (enExample)
WO (1) WO2002002563A2 (enExample)
ZA (1) ZA200300793B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013191112A1 (ja) * 2012-06-22 2013-12-27 住友化学株式会社 縮合複素環化合物
KR20180106597A (ko) * 2017-03-21 2018-10-01 한국화학연구원 [1,2,4]트리아졸로[4,3-a]퀴노잘린 아미노 페닐 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 BET 단백질 관련 질환의 예방 또는 치료용 약학적 조성물
JP2023521809A (ja) * 2020-04-14 2023-05-25 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 置換された{1,2,4,}トリアゾロ{1,5-a}ピリミジン化合物および微小管の安定化におけるその使用

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6255309B1 (en) * 1999-03-19 2001-07-03 American Cyanomid Co. Fungicidal trifluoromethylalkylamino-triazolopyrimidines
WO2002038565A2 (de) * 2000-11-13 2002-05-16 Basf Aktiengesellschaft 7-(r)-amino-triazolopyrimidine, deren herstellung und verwendung zur bekämpfung von pflanzenpathogenen pilzen
ATE287405T1 (de) * 2001-04-11 2005-02-15 Wyeth Corp 5-halogen-6-phenyl-7-fluoroalkylamino- triazolopyrimidine als fungizide
ATE274518T1 (de) * 2001-04-11 2004-09-15 Basf Ag 6-(2-chlor-6-fluor-phenyl)-triazolpyrimidine
DE10121101A1 (de) * 2001-04-27 2002-10-31 Bayer Ag Triazolopyrimidine
DE10121162A1 (de) * 2001-04-30 2002-10-31 Bayer Ag Triazolopyrimidine
DE10124208A1 (de) 2001-05-18 2002-11-21 Bayer Ag Verwendung von Triazolopyrimidin-Derivaten als Mikrobizide
HUP0401746A3 (en) * 2001-07-18 2008-02-28 Basf Ag Substituted 6-(2-tolyl)-triazolopyrimidines as fungicides
WO2003080615A1 (de) 2002-03-21 2003-10-02 Basf Aktiengesellschaft Fungizide triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
JPWO2004011467A1 (ja) * 2002-07-29 2005-12-15 北興化学工業株式会社 トリアゾロピリミジン誘導体および農園芸用殺菌剤
UA80304C2 (en) * 2002-11-07 2007-09-10 Basf Ag Substituted 6-(2-halogenphenyl)triazolopyrimidines
US20060211573A1 (en) * 2003-03-31 2006-09-21 Blasco Jordi T 7-(Akenylamino)triazolopyrimidines, method for the production thereof and use thereof in controlling harmful fungi and substances containing said triazolopyrimidines
DE10325133A1 (de) * 2003-06-04 2004-12-23 Bayer Cropscience Ag Triazolopyrimidine
WO2004108136A1 (en) * 2003-06-04 2004-12-16 Vernalis (Cambridge) Limited Triazolo `1 , 5-a!pyrimidines and their use in medicine
DE10328171A1 (de) * 2003-06-24 2005-01-13 Bayer Cropscience Ag Triazolopyrimidine
DE10328173A1 (de) * 2003-06-24 2005-01-13 Bayer Cropscience Ag Triazolopyrimidine
DE10328481A1 (de) * 2003-06-25 2005-01-13 Bayer Ag Triazolopyrimidine
JP4695595B2 (ja) 2003-09-24 2011-06-08 ワイス・ホールディングズ・コーポレイション 抗癌剤としての6−アリール−7−ハロ−イミダゾ[1,2−a]ピリミジン類
MXPA06003206A (es) * 2003-09-24 2006-06-23 Wyeth Corp 6-[(sustituido)fenil]triazolopirimidinas como agentes anticancer.
US7419982B2 (en) 2003-09-24 2008-09-02 Wyeth Holdings Corporation Crystalline forms of 5-chloro-6-{2,6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(1S)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine salts
WO2005037837A1 (ja) * 2003-10-17 2005-04-28 Nippon Kayaku Kabushiki Kaisha 置換2−アミノ−[1,2,4]トリアゾロ[1,5−a]ピリミジン誘導体及びその用途
JP4606015B2 (ja) * 2003-11-25 2011-01-05 日本化薬株式会社 [1,2,4]トリアゾロ[1,5−a]ピリミジン誘導体の新規医薬用途
MY179926A (en) 2003-12-08 2020-11-19 Wyeth Corp Process for the preparation of tubulin inhibitors
CN1890243A (zh) * 2003-12-17 2007-01-03 巴斯福股份公司 6-(2,4,6-三卤代苯基)三唑并嘧啶、其制备方法及其在防治病原性真菌中的用途以及包含所述物质的组合物
US20070149588A1 (en) * 2003-12-17 2007-06-28 Tormo I Blasco Jordi 6-(2,3,6-Trifluorophenyl)triazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds
WO2005095404A2 (de) * 2004-03-30 2005-10-13 Basf Aktiengesellschaft 6-(2-fluorphenyl)-triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
BRPI0510804A (pt) * 2004-05-17 2007-11-06 Basf Ag compostos, uso de um composto, agente adequado para combater fungos nocivos, e, processo para combater fungos fitopatogênicos
CN1964629A (zh) * 2004-06-09 2007-05-16 巴斯福股份公司 三唑并嘧啶化合物及其在防治有害真菌中的用途
EA200700007A1 (ru) * 2004-06-25 2007-08-31 Басф Акциенгезельшафт Триазолопиримидиновые соединения и их применение для борьбы с патогенными грибами
US20070155738A1 (en) * 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
US20060293345A1 (en) * 2005-05-20 2006-12-28 Christoph Steeneck Heterobicyclic metalloprotease inhibitors
WO2007011759A2 (en) * 2005-07-15 2007-01-25 Kalypsys, Inc. Inhibitors of mitotic kinesin
WO2007075465A1 (en) * 2005-12-16 2007-07-05 Wyeth Dimers and adducts of 6-[(substituted) phenyl] triazolopyrimidines useful as anticancer agents
AR059649A1 (es) * 2006-02-28 2008-04-16 Basf Ag 6- fenil 7-amino - amino (1,2,4) -triazolo (1,5-a) pirimidinas y su su uso para el combate de hongos daninos
WO2007116011A2 (de) * 2006-04-10 2007-10-18 Basf Se Substituierte triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
JP5231829B2 (ja) 2007-02-15 2013-07-10 石原産業株式会社 ピリジル−トリアゾロピリミジン誘導体又はその塩、それらを含有する有害生物防除剤並びにそれらの製造方法
UY31293A1 (es) 2007-08-14 2009-03-31 Pirimidinas biciclicas fusionadas
CN103889428A (zh) * 2010-10-04 2014-06-25 肝炎与病毒研究所 乙型肝炎病毒抗原分泌的新型抑制剂
CN103360398B (zh) * 2013-07-22 2015-03-25 山东大学 一种三唑并嘧啶类hiv-1逆转录酶抑制剂及其制备方法与应用
GB201504565D0 (en) 2015-03-18 2015-05-06 Takeda Pharmaceutical Novel compounds
US11390626B2 (en) 2019-01-29 2022-07-19 Tosk, Inc. Pyrazolopyrimidine modulators of RAS GTPase
US12528796B2 (en) 2019-04-15 2026-01-20 Tosk, Inc. Modulators of RAS GTPase
US12110294B2 (en) 2020-05-01 2024-10-08 Gilead Sciences, Inc. CD73 compounds
US20230279006A1 (en) * 2020-07-08 2023-09-07 Klotho Therapeutics, Inc. Novel compounds and methods for increasing klotho gene expression
US12180220B2 (en) 2020-10-14 2024-12-31 Tosk, Inc. Heteroaryl modulators of RAS GTPase
AU2022376954B2 (en) 2021-10-29 2026-04-23 Gilead Sciences, Inc. Cd73 compounds
CN118475581A (zh) * 2022-01-25 2024-08-09 瑞石生物医药有限公司 一种ccr4小分子拮抗剂及其用途

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD55956A (enExample) *
DE55956C (de) CH. GROOMBRIDGE und W. A. SOUTH in London, 40 New Bond Street Bremskurbel für Pferdebahn- und andere Wagen
DE61269C (de) 1891-04-01 1892-03-23 J. NEWBURG in Berlin O., Am Schlesischen Bahnhof Nr. 5 Waschmaschine
JPS5827773B2 (ja) * 1980-02-08 1983-06-11 持田製薬株式会社 癌転移抑制剤
US4444774A (en) * 1982-07-29 1984-04-24 American Cyanamid Company 7-Heteroaryl[1,2,4]triazolo[1,5-a]pyrimidines
GB8719368D0 (en) * 1987-08-15 1987-09-23 Wellcome Found Heterocyclic compounds
JPH02212488A (ja) * 1989-02-13 1990-08-23 Shinichiro Shimizu トリアゾールピリミジン誘導体
US5593996A (en) * 1991-12-30 1997-01-14 American Cyanamid Company Triazolopyrimidine derivatives
US5387747A (en) * 1992-02-24 1995-02-07 Laboratoires Upsa Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present
IL108747A (en) * 1993-03-04 1999-03-12 Shell Int Research Mushroom-killing preparations containing a history of 6 metamorphoses of 5 - 7 Dihalo - 1, 2 - 4 Triazlo [A-1,5] Pyrimidine Certain such new compounds and their preparation
GB9321162D0 (en) * 1993-10-13 1993-12-01 Boots Co Plc Therapeutic agents
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
US5948783A (en) * 1997-04-14 1999-09-07 American Cyanamid Company Fungicidal trifluoromethylalkylamino-triazolopyrimidines
US6255309B1 (en) * 1999-03-19 2001-07-03 American Cyanomid Co. Fungicidal trifluoromethylalkylamino-triazolopyrimidines
US6117876A (en) * 1997-04-14 2000-09-12 American Cyanamid Company Fungicidal trifluorophenyl-triazolopyrimidines
US5994360A (en) * 1997-07-14 1999-11-30 American Cyanamid Company Fungicidal 5-alkyl-triazolopyrimidines
US6020338A (en) * 1998-02-11 2000-02-01 American Cyanamid Company Fungicidal 7-alkyl-triazolopyrimidines
FR2784380B1 (fr) * 1998-09-25 2002-09-06 American Cyanamid Co Triazolopyrimidines 7-oxy- et 7-thio-substituees fongicides
US6380202B1 (en) * 1998-09-25 2002-04-30 Basf Aktiengesellschaft Fungicidal fluoro-substituted 7-heterocyclyl-triazolopyrimidines
US6165940A (en) * 1998-09-25 2000-12-26 American Cyanamid Co. Non-aqueous suspension concentrate
MY125533A (en) * 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
JP2001322933A (ja) * 2000-05-15 2001-11-20 Ucb Sa Cd40シグナル遮断剤
DE10121101A1 (de) * 2001-04-27 2002-10-31 Bayer Ag Triazolopyrimidine
DE10121102A1 (de) * 2001-04-27 2002-11-07 Bayer Ag Triazolopyrimidine
DE10121162A1 (de) * 2001-04-30 2002-10-31 Bayer Ag Triazolopyrimidine
US7037902B2 (en) * 2002-07-03 2006-05-02 Receptron, Inc. Affinity small molecules for the EPO receptor
MXPA06003206A (es) * 2003-09-24 2006-06-23 Wyeth Corp 6-[(sustituido)fenil]triazolopirimidinas como agentes anticancer.
US7419982B2 (en) * 2003-09-24 2008-09-02 Wyeth Holdings Corporation Crystalline forms of 5-chloro-6-{2,6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(1S)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine salts

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013191112A1 (ja) * 2012-06-22 2013-12-27 住友化学株式会社 縮合複素環化合物
JPWO2013191112A1 (ja) * 2012-06-22 2016-05-26 住友化学株式会社 縮合複素環化合物
KR20180106597A (ko) * 2017-03-21 2018-10-01 한국화학연구원 [1,2,4]트리아졸로[4,3-a]퀴노잘린 아미노 페닐 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 BET 단백질 관련 질환의 예방 또는 치료용 약학적 조성물
KR101995533B1 (ko) 2017-03-21 2019-07-02 한국화학연구원 [1,2,4]트리아졸로[4,3-a]퀴노잘린 아미노 페닐 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 BET 단백질 관련 질환의 예방 또는 치료용 약학적 조성물
JP2023521809A (ja) * 2020-04-14 2023-05-25 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 置換された{1,2,4,}トリアゾロ{1,5-a}ピリミジン化合物および微小管の安定化におけるその使用
JP7646140B2 (ja) 2020-04-14 2025-03-17 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 置換された{1,2,4,}トリアゾロ{1,5-a}ピリミジン化合物および微小管の安定化におけるその使用

Also Published As

Publication number Publication date
HUP0300798A2 (hu) 2003-07-28
NO20026195L (no) 2003-02-27
HK1052646A1 (zh) 2003-09-26
US7329663B2 (en) 2008-02-12
EP1307200A2 (en) 2003-05-07
WO2002002563A2 (en) 2002-01-10
ZA200300793B (en) 2004-07-20
CN1592624A (zh) 2005-03-09
MXPA02011913A (es) 2003-04-22
EA006483B1 (ru) 2005-12-29
NO20026195D0 (no) 2002-12-23
US20020068744A1 (en) 2002-06-06
NZ523807A (en) 2004-09-24
KR20030013475A (ko) 2003-02-14
BG107277A (bg) 2004-01-30
AU2001273062B2 (en) 2005-11-24
PL360027A1 (en) 2004-09-06
IN2003KO00001A (enExample) 2005-12-02
AU7306201A (en) 2002-01-14
SK18412002A3 (sk) 2003-06-03
AR034553A1 (es) 2004-03-03
HUP0300798A3 (en) 2006-02-28
EA200300091A1 (ru) 2003-08-28
BR0112038A (pt) 2003-04-01
CZ20024150A3 (cs) 2003-09-17
CA2413802A1 (en) 2002-01-10
WO2002002563A3 (en) 2003-01-03
GEP20053688B (en) 2005-12-12
IL152869A0 (en) 2003-06-24

Similar Documents

Publication Publication Date Title
US7329663B2 (en) Substituted-triazolopyrimidines as anticancer agents
AU2001273062A1 (en) Substituted-triazolopyrimidines as anticancer agents
US8436004B2 (en) Bicycloaniline derivative
CA2841458C (en) Tricyclic heterocyclic compounds and jak inhibitors
KR101686685B1 (ko) 피라졸로피리미딘 jak 억제제 화합물 및 방법
JP5572388B2 (ja) キナーゼ阻害剤としてのイミダゾトリアジンおよびイミダゾピリミジン
DE69815317T2 (de) Pyrrolo[2,3-d]pyrimidine und ihre verwendung als tyrosinkinase-inhibitoren
CA2496194C (en) Phenyl-substituted pyrazolopyrimidines
US7196090B2 (en) Kinase inhibitors
JP5199882B2 (ja) 高−増殖性障害及び脈管形成と関連する疾患の処置のために有用な置換4−アミノ−ピロロトリアジン誘導体
JP5400626B2 (ja) 置換イミダゾおよびトリアゾロピリミジン類
US20070021443A1 (en) Purine and imidazopyridine derivatives for immunosuppression
TW200838540A (en) Sulfamoyl-containing derivatives and uses thereof
JP2010500365A (ja) キナーゼ阻害剤としてのトリアゾロトリアジン
JP2013504594A (ja) 薬学的に有用な複素環置換ラクタム
JP2016506921A (ja) アミノ置換イソチアゾール
KR20070026695A (ko) 접합 헤테로시클릭 화합물
JP4695595B2 (ja) 抗癌剤としての6−アリール−7−ハロ−イミダゾ[1,2−a]ピリミジン類
KR20060127947A (ko) 증식성 질환의 치료에 유용한 피롤로 피리미딘 유도체
FR2969613A1 (fr) Nouveaux derives de 1,2,3,4-tetrahydro-pyrimido{1,2-a}pyrimidin-6-one, leur preparation et leur utilisation pharmaceutique
HK1232539A1 (en) Tricyclic heterocyclic compounds and jak inhibitors
HK1124840B (en) Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors